Issues
-
Cover image
Cover Image
Cover: Histological section of the cartilage endplate including the annulus fibrosus and underlying vertebral bone from a 1-year-old mouse specimen, stained with Safranin-O/Fast Green. See article by McCann et al. on page 73. - PDF Icon PDF LinkTable of contents
In This Issue
Research Highlights
Editorial
A Model For Life
Breaking down barriers to clinical translation: an interview with Laurie Glimcher
Laurie Glimcher is a physician-scientist with a true passion for research. In this interview, she discusses her early career, key issues in successful clinical translation and her move to become Dean of Weill Cornell Medical College in Manhattan.
Clinical Puzzle
Special Article
Commentaries
Perspectives
Podcast
Research Articles
The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium
Research Report
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Registration is now open for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, we will present the very latest advances in modelling human genetic disease.
A new call for papers is underway

Showcase your latest research in our upcoming special issue Translating Multiscale Research in Rare Disease, coordinated by DMM Editors Monica Justice, Karen Liu and Monkol Lek, and Guest Editor Kate Rauen. The deadline for submitting articles to the special issue is Monday 6 November 2023.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that aim to move heart failure to heart success by fundamentally addressing the roots of failure to identify curative strategies.
Adult zebrafish as advanced models of human disease

Editor-in-Chief Liz Patton and Editorial Board member Rich White discuss the unique advantages of adult zebrafish for studying human disease biology. Read the Open Access Editorial here.
The Forest of Biologists

The Forest of Biologists is a biodiversity initiative created by The Company of Biologists, with support from the Woodland Trust. For every Research and Review article published in Disease Models & Mechanisms a native tree is planted in a UK forest. In addition to this we are protecting and restoring ancient woodland and are dedicating these trees to our peer reviewers. Visit our virtual forest to learn more.